Ten years of surveillance for invasive streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Everett, Dean B ^a,b   Mukaka, Mavuto ^a   Denis, Brigitte ^a   Gordon, Stephen B ^a,c   Carrol, Enitan D ^a,b   van Oosterhout, Joep J ^a   Molyneux, Elizabeth M ^a   Molyneux, Malcolm ^a,c   French, Neil ^d   Heyderman, Robert S ^a,c  

^a UNIVERSITY OF MALAWI   (Malawi)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G; ANTIRETROVIRUS AGENT; RAIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIVIRAL THERAPY; ARTICLE; BACTERIUM ISOLATE; BLOOD CULTURE; CEREBROSPINAL FLUID CULTURE; CHEMOPROPHYLAXIS; CHILD; DISEASE SURVEILLANCE; HUMAN; MAJOR CLINICAL STUDY; MALAWI; MULTIDRUG RESISTANCE; PNEUMOCOCCAL INFECTION; PREVALENCE; SCALE UP; SEASONAL VARIATION; SEROPREVALENCE; STREPTOCOCCUS PNEUMONIAE; ANTIBIOTIC PROPHYLAXIS; BLOOD; DRUG EFFECT; HEALTH SURVEY; PATHOGENICITY; SEASON;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PNEUMONIAE;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CHILD; DRUG RESISTANCE, MICROBIAL; HUMANS; MALAWI; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; RAIN; SEASONS; STREPTOCOCCUS PNEUMONIAE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 79952680703     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017765     Document Type: Article

References (61)

1. Embry A, Hinojosa E, Orihuela C, (2007) Regions of Diversity 8, 9 and 13 contribute to Streptococcus pneumoniae virulence. BMC Microbiology 7: 80.
2. Klein DL, (1999) Pneumococcal disease and the role of conjugate vaccines. Microb Drug Resist 5: 147-157.
3. Poland GA, (1999) The burden of pneumococcal disease: the role of conjugate vaccines. Vaccine 17: 1674-1679.
4. Spratt BG, Hanage WP, Brueggemann AB, (2004) Evolutionary and population biology of Streptococcus pneumoniae. In: E.I T, editors. The pneumococcus Washington (D.C.) ASM Press pp. 119-135.
5. Gilks CF, Ojoo SA, Ojoo JC, Brindle RJ, Paul J, et al. (1996) Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya. Lancet 347: 718-723.
6. Gordon S, Walsh A, Chaponda M, Gordon M, Soko D, et al. (2000) Bacterial Meningitis in Malawian Adults: Pneumococcal Disease is Common, Severe, and Seasonal. Clinical Infectious Diseases 31: 53-57.
7. Gordon SB, Chaponda M, Walsh AL, Whitty CJ, Gordon MA, et al. (2002) Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival. Aids 16: 1409-1417.
8. Carrol ED, Guiver M, Nkhoma S, Mankhambo LA, Marsh J, et al. (2007) High pneumococcal DNA loads are associated with mortality in Malawian children with invasive pneumococcal disease. Pediatr Infect Dis J 26: 416-422.
9. Madhi SA, Petersen K, Madhi A, Wasas A, Klugman KP, (2000) Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children. Pediatr Infect Dis J 19: 1141-1147.
10. Molyneux EM, Walsh AL, Forsyth H, Tembo M, Mwenechanya J, et al. (2002) Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet 360: 211-218.
11. Riou JY, Djibo S, Sangare L, Lombart JP, Fagot P, et al. (1996) A predictable comeback: the second pandemic of infections caused by Neisseria meningitidis serogroup A subgroup III in Africa, 1995. Bull World Health Organ 74: 181-187.
12. UNAIDS (2008) Epidemiological Fact Sheet on HIV and AIDS:.
13. Rogerson SR, Gladstone M, Callaghan M, Erhart L, Rogerson SJ, et al. (2004) HIV infection among paediatric in-patients in Blantyre, Malawi. Trans R Soc Trop Med Hyg 98: 544-552.
14. Molyneux EM, Tembo M, Kayira K, Bwanaisa L, Mweneychanya J, et al. (2003) The effect of HIV infection on paediatric bacterial meningitis in Blantyre, Malawi. Arch Dis Child 88: 1112-1118.
15. Lewis DK, Callaghan M, Phiri K, Chipwete J, Kublin JG, et al. (2003) Prevalence and indicators of HIV and AIDS among adults admitted to medical and surgical wards in Blantyre, Malawi. Trans R Soc Trop Med Hyg 97: 91-96.
16. Scarborough M, Gordon SB, Whitty CJ, French N, Njalale Y, et al. (2007) Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med 357: 2441-2450.
17. French N, Gordon SB, Mwalukomo T, White SA, Mwafulirwa G, et al. (2010) A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults. N Engl J Med 362: 812-822.
18. Harries AD, Zachariah R, Jahn A, Schouten EJ, Kamoto K, (2009) Scaling Up Antiretroviral Therapy in Malawi-Implications for Managing Other Chronic Diseases in Resource-Limited Countries. JAIDS Journal of Acquired Immune Deficiency Syndromes 52: S14-S16 10.1097/QAI.1090b1013e3181bbc1099e.
19. Malawi Antiretroviral Treatment Programme (2010) Quarterly Report: Results up to 31st December 2009. Ministry of Health pp. 1-12.
20. Jahn A, (2010) Data on ARV scale up and Cotrimoxazole prophylaxis register.
21. Heffernan RT, Barrett NL, Gallagher KM, Hadler JL, Harrison LH, et al. (2005) Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000. J Infect Dis 191: 2038-2045.
22. Nunes MC, von Gottberg A, de Gouveia L, Cohen C, Moore DP, et al. (2010) The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis. AIDS.
23. Adegbola RA, Hill PC, Secka O, Ikumapayi UN, Lahai G, et al. (2006) Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003. Trop Med Int Health 11: 1128-1135.
24. Gordon MA, Walsh AL, Chaponda M, Soko D, Mbvwinji M, et al. (2001) Bacteraemia and mortality among adult medical admissions in Malawi-predominance of non-typhi salmonellae and Streptococcus pneumoniae. J Infect 42: 44-49.
25. McGee L, McDougal L, Zhou J, Spratt BG, Tenover FC, et al. (2001) Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J Clin Microbiol 39: 2565-2571.
26. Mudhune S, Wamae M, (2009) Report on invasive disease and meningitis due to Haemophilus influenzae and Streptococcus pneumonia from the Network for Surveillance of Pneumococcal Disease in the East African Region. Clin Infect Dis 48 (Suppl 2): S147-152.
27. Reinert RR, (2009) The antimicrobial resistance profile of Streptococcus pneumoniae. Clin Microbiol Infect 15 (Suppl 3): 7-11.
28. Wolter N, von Gottberg A, du Plessis M, de Gouveia L, Klugman KP, (2008) Molecular basis and clonal nature of increasing pneumococcal macrolide resistance in South Africa, 2000-2005. Int J Antimicrob Agents 32: 62-67.
29. van Oosterhout JJ, Laufer MK, Graham SM, Thumba F, Perez MA, et al. (2005) A community-based study of the incidence of trimethoprim-sulfamethoxazole-preventable infections in Malawian adults living with HIV. J Acquir Immune Defic Syndr 39: 626-631.
30. Lynch JP 3rd, Zhanel GG, (2009) Streptococcus pneumoniae: does antimicrobial resistance matter? Semin Respir Crit Care Med 30: 210-23.
31. Gwanzura L, Pasi C, Nathoo KJ, Hakim J, Gangaidzo I, et al. (2003) Rapid emergence of resistance to penicillin and trimethoprim-sulphamethoxazole in invasive Streptococcus pneumoniae in Zimbabwe. Int J Antimicrob Agents 21: 557-561.
32. Kariuki S, Muyodi J, Mirza B, Mwatu W, Daniels JJ, (2003) Antimicrobial susceptibility in community-acquired bacterial pneumonia in adults. East Afr Med J 80: 213-217.
33. Liebowitz LD, Slabbert M, Huisamen A, (2003) National surveillance programme on susceptibility patterns of respiratory pathogens in South Africa: moxifloxacin compared with eight other antimicrobial agents. J Clin Pathol 56: 344-347.
34. Barrow G, Feltham RKA, (1993) Manual for the identification of medical bacteria. In: Steele Ca, editors. Cambridge University Press.
35. Mtunthama N, Gordon SB, Kusimbwe T, Zijlstra EE, Molyneux ME, et al. (2008) Blood culture collection technique and pneumococcal surveillance in Malawi during the four year period 2003-2006: an observational study. BMC Infect Dis 8: 137.
36. (2001) BSAC disc diffusion method for antimicrobial susceptibility testing.:British Society of Antimicrobial Chemotherapy (BSAC) working party.
37. Malawi Go, (2010) Quarterly HIV Programme Report. In: Health Mo, editors.
38. All-Party Parliamentary Group on Pneumococcal Disease Prevention in the Developing World (2008) Improving global health by preventing pneumococcal disease. British Parliament pp. 1-35.
39. Jones RN, Jacobs MR, Sader HS., Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia. Int J Antimicrob Agents.
40. Dagan R, (2009) Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Infect 15 (Suppl 3): 16-20.
41. Feikin DR, Jagero G, Aura B, Bigogo GM, Oundo J, et al. (2010) High rate of pneumococcal bacteremia in a prospective cohort of older children and adults in an area of high HIV prevalence in rural western Kenya. BMC Infect Dis 10: 186.
42. Gill CJ, Mwanakasale V, Fox MP, Chilengi R, Tembo M, et al. (2008) Impact of human immunodeficiency virus infection on Streptococcus pneumoniae colonization and seroepidemiology among Zambian women. J Infect Dis 197: 1000-1005.
43. French N, Watera C, Moi K, Whitworth J, Gilks CF, (2004) Pneumococcal carriage is higher in Ugandan adults infected with HIV than in uninfected, shows seasonal variation and is directly associated with pneumococcal disease rates. 4th International Symposium on Pneumococci and Pneumococcal Diseases.
44. Medina MJ, Greene CM, Gertz RE, Facklam RR, Jagero G, et al. (2005) Novel antibiotic-resistant pneumococcal strains recovered from the upper respiratory tracts of HIV-infected adults and their children in Kisumu, Kenya. Microb Drug Resist 11: 9-17.
45. Crewe-Brown HH, Karstaedt AS, Saunders GL, Khoosal M, Jones N, et al. (1997) Streptococcus pneumoniae blood culture isolates from patients with and without human immunodeficiency virus infection: alterations in penicillin susceptibilities and in serogroups or serotypes. Clin Infect Dis 25: 1165-1172.
46. Gilks CF, (1997) Royal Society of Tropical Medicine and Hygiene meeting at Manson House, London, 12 December 1996. HIV and pneumococcal infection in Africa. Clinical, epidemiological and preventative aspects. Trans R Soc Trop Med Hyg 91: 627-631.
47. Klugman KP, Madhi SA, Feldman C, (2007) HIV and pneumococcal disease. Curr Opin Infect Dis 20: 11-15.
48. Dowell SF, Kupronis BA, Zell ER, Shay DK, (2000) Mortality from pneumonia in children in the United States, 1939 through 1996. N Engl J Med 342: 1399-1407.
49. Dowell SF, Whitney CG, Wright C, Rose CE Jr, Schuchat A, (2003) Seasonal patterns of invasive pneumococcal disease. Emerg Infect Dis 9: 573-579.
50. Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, et al. (2005) Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Am J Med 118: 285-291.
51. Laurichesse H, Grimaud O, Waight P, Johnson AP, George RC, et al. (1998) Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995. Commun Dis Public Health 1: 22-27.
52. Gessner BD, Mueller JE, Yaro S, (2010) African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults. BMC Infect Dis 10: 22.
53. Grimwade K, Gilks C, (2001) Cotrimoxazole prophylaxis in adults infected with HIV in low-income countries. Curr Opin Infect Dis 14: 507-512.
54. Grimwade K, Swingler, (2003) Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV. Cochrane Database Syst Rev: CD003108.
55. Anglaret X, Eholie S, (2008) Prophylaxis with co-trimoxazole for HIV infected adults in Africa. Bmj 337: a304.
56. Feikin DR, Feldman C, Schuchat A, Janoff EN, (2004) Global strategies to prevent bacterial pneumonia in adults with HIV disease. Lancet Infect Dis 4: 445-455.
57. Watera C, Todd J, Muwonge R, Whitworth J, Nakiyingi-Miiro J, et al. (2006) Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda. J Acquir Immune Defic Syndr 42: 373-378.
58. Klugman KP, Lonks JR, (2005) Hidden epidemic of macrolide-resistant pneumococci. Emerg Infect Dis 11: 802-807.
59. Siira L, Rantala M, Jalava J, Hakanen AJ, Huovinen P, et al. (2009) Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006. Antimicrob Agents Chemother 53: 2066-2073.
60. Klugman KP, (2001) Antibiotic selection of multiply resistant pneumococci. Clin Infect Dis 33: 489-491.
61. Government of Malawi (2008) The 2007 Malawi Millenium Development Goal Report.